Analytical Champions: Tao Chen
A new series championing analytical scientists in pharma begins with Genentech’s rising star
False
A new series championing analytical scientists in pharma begins with Genentech’s rising star
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
August 20, 2026
6 min read
From multiple sclerosis to AI-driven discovery, Daniel Vitt reflects on the future of drug development
August 19, 2026
5 min read
Can iPSC platforms deliver consistent, commercial-scale cell therapies for large patient populations?
August 18, 2026
10 min read
From collapsing legacy models to the rise of Chinese biotech, industry leaders are being forced to rethink how drugs are developed, funded, and brought to market
August 17, 2026
5 min read
Biopharma labs are investing heavily in digital tools, but without trusted data architecture, each new platform can add another point of failure
False
Affiliations:
Specialties:
Areas of Expertise: